Significantly more patients with baseline CD4 ≤100/μl had a new or recurrent ADE with continuation (38 (46.3%)) compared to with interruption (23 (30.7%), p = 0.04). This evidence concerns the gene CD4 and acute disseminated encephalomyelitis.